The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> July 21, 2000

Michael Ashton – Skyepharma (skp.l)

Michael Ashton is the CEO of SkyePharma PLC, a drug delivery company with research and development activities in Switzerland, manufacturing in France, and Head Office in London. Profile
TWST: SkyPharma announced the development contract with Kirin Brewery Company, Ltd. last week. Can you provide some details of the agreement?



Mr. Ashton: It is a biological-type

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
GE Aerospace (General Electric Company)
Walmart Inc.
IBM (International Business Machines Corp.)
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the Founder and CEO: Wetour Robotics Ltd. (NASDAQ:WETO)
Interview with the Founder, Chairman and CEO: SS Innovations International, Inc. (NASDAQ:SSII)
Interview with the Chairman and CEO: ReposiTrak Inc. (NYSE:TRAK)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Active Hedging Strategy Aims to Smooth Returns Across Market Cycles
Fund Manager Expands AI Trade Into Energy, Logistics and Land
Double-Digit Dividend Strategy Tilts Toward Quality Names
ANALYST INTERVIEWS
Engineering Software Remains Resilient Despite Manufacturing Weakness
Semiconductor Equipment Positioned for Extended AI Investment Cycle
Nvidia Capacity Limits Create Opening for AMD and Broadcom
Since 1963
© The Wall Street Transcript 2016, 2026
Terms and Conditions
Privacy Policy